| Financial Year |
March 31 2023 |
| Monetary Funds |
127,605,392.73 |
| Held-for-trading Financial Assets |
1,013.91 |
| Notes Receivable |
38,047,485.50 |
| Accounts Receivable |
844,794,411.60 |
| Advances to Suppliers |
25,272,125.36 |
| Other Receivables |
4,909,229.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
332,336,111.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,311,905.27 |
| Total Current Assets |
1,505,116,840.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
32,233,738.30 |
| Investment Properties |
67,786,470.21 |
| Fixed Assetes |
362,486,383.30 |
| Under-construction Projects |
6,140,079.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
124,393,534.20 |
| R&D expenses |
-- |
| Goodwill |
2,775,558.22 |
| Long-Term Deferred and Prepaid Expenses |
5,435,311.84 |
| Deferred Income Tax Assets |
23,588,208.31 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
633,925,788.76 |
| Total Assets |
2,139,042,629.65 |
| Short-Term Loans |
241,127,219.62 |
| Trading Financial liabilities |
-- |
| Notes Payable |
48,123,738.79 |
| Accounts Payable |
538,010,259.02 |
| Accounts Received In Advance |
528,893.45 |
| Employee Compensation Payable |
15,448,431.55 |
| Taxes Payable |
18,604,711.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,092,221.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,538,925.84 |
| Other Current Liabilities |
13,692,050.48 |
| Sub-Total of Current Liabilities |
898,951,139.35 |
| Long-term Loans |
121,708,121.54 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,772,016.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
176,297,394.30 |
| Total Liabilities |
1,075,248,533.65 |
| Paid-In Capital(Or Share Stock) |
160,000,000.00 |
| Capital Surplus |
337,323,452.52 |
| Surplus Reserve |
36,871,150.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
332,352,246.14 |
| Minority Stockholder's Interest |
197,247,246.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
866,546,849.57 |
| Owner's Equity（Stockholder's Equity） |
1,063,794,096.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,139,042,629.65 |
